There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .
Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction
We investigated whether disclosure of coronary heart disease ( CHD ) genetic risk influences perceived personal control ( PPC ) and genetic counseling satisfaction ( GCS ) . Participants ( n = 207 , age : 45–65 years ) were r and omized to receive estimated 10‐year risk of CHD based on a conventional risk score ( CRS ) with or without a genetic risk score ( GRS ) . Risk estimates were disclosed by a genetic counselor who also review ed how GRS altered risk in those r and omized to CRS+GRS . Each participant subsequently met with a physician and then completed surveys to assess PPC and GCS . Participants who received CRS+GRS  had higher PPC than those who received CRS alone although the absolute difference was small ( 25.2 ± 2.7 vs 24.1 ± 3.8 , p = 0.04 ) . A greater proportion of CRS+GRS participants had higher GCS scores ( 17.3 ± 5.3 vs 15.9 ± 6.3 , p = 0.06 ) . In  the CRS+GRS  group , PPC and GCS scores were not correlated with GRS . Within both groups , PPC and GCS scores were similar in patients with or without family history ( p = NS ) . In conclusion , patients who received their genetic risk of CHD had higher PPC and tended to have higher GCS . Our findings suggest that disclosure of genetic risk of CHD together with conventional risk estimates is appreciated by patients . Whether this results in improved outcomes needs additional investigation
There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .